SOPH
SOPHiA GENETICS SA
$5.00
+$0.14(+2.88%)
50
Overall
45
Value
60
Tech
47
Quality
Market Cap
$355.48M
Volume
67.19K
52W Range
$2.59 - $5.70
Target Price
$8.00
Company Overview
| Mkt Cap | $355.48M | Price | $5.00 |
| Volume | 67.19K | Change | +2.88% |
| P/E Ratio | -5.0 | Open | $4.84 |
| Revenue | $65.2M | Prev Close | $4.86 |
| Net Income | $-70.6M | 52W Range | $2.59 - $5.70 |
| Div Yield | N/A | Target | $8.00 |
| Overall | 50 | Value | 45 |
| Quality | 47 | Technical | 60 |
No chart data available
About SOPHiA GENETICS SA
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is based in Rolle, Switzerland.
Sector: Industrials
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SOPH | $5.00 | +2.9% | 67.19K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |